Trimethylamine N-oxide (TMAO), a key metabolite derived from the gut microbial metabolism of choline, has recently been implicated as a significant contributor to the development of several chronic diseases, including diabetes, cardiovascular disease, and chronic kidney disease. Its detrimental effects have garnered widespread attention in the scientific community. Inflammatory bowel disease (IBD), marked by persistent and recurring gastrointestinal inflammation, is a significant global health issue. Emerging evidence highlights a critical role for TMAO in the pathogenesis of IBD. This review comprehensively summarizes current research on the association between TMAO and IBD, with a particular focus on the mechanisms by which TMAO regulates immunometabolism in diseases.
基金:
National Natural Science Youth Fund [82200576]; Medical Research Project of Jiangsu Provincial Health Commission [Z20201015]; Research Project of Jiangsu Society of Traditional Chinese Medicine [CYTF2024045]; Youth Science Fund Project of Kunshan Hospital of Chinese Medicine [2024QNJJ02]; Kunshan Youth Science and Technology Talent Support Project [2025KSTJ04]
第一作者机构:[1]Kunshan Hosp Chinese Med, Dept Prevent Treatment Dis, Kunshan, Peoples R China[2]Suzhou Key Lab Integrated Tradit Chinese & Western, Kunshan, Peoples R China
共同第一作者:
通讯作者:
通讯机构:[2]Suzhou Key Lab Integrated Tradit Chinese & Western, Kunshan, Peoples R China[5]Kunshan Hosp Chinese Med, Dept Gastroenterol, Kunshan, Peoples R China
推荐引用方式(GB/T 7714):
Wang Siyu,Ni Yifan,Zhou Shuwei,et al.Effects of choline metabolite-trimethylamine N-oxide on immunometabolism in inflammatory bowel disease[J].FRONTIERS IN IMMUNOLOGY.2025,16:doi:10.3389/fimmu.2025.1591151.
APA:
Wang, Siyu,Ni, Yifan,Zhou, Shuwei,Peng, Huiping,Cao, Ying...&Wang, Yaodong.(2025).Effects of choline metabolite-trimethylamine N-oxide on immunometabolism in inflammatory bowel disease.FRONTIERS IN IMMUNOLOGY,16,
MLA:
Wang, Siyu,et al."Effects of choline metabolite-trimethylamine N-oxide on immunometabolism in inflammatory bowel disease".FRONTIERS IN IMMUNOLOGY 16.(2025)